Stock Analysis of Adicet Bio Inc (ACET) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ACET
Close 1.60
Change 0.0300 / 1.91 %
Volume 1057.92 K
Vol Change 212027 / 25.07 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bearish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Low Stability Stock


Fundamental View of Adicet Bio Inc
PE (TTM)

-123.39

Very Poor
Price / Book

76.40

Very Poor
Price / Sales

1337.75

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

131471 K

Enterprise Value

-25018.64 K

ROA (TTM)

-53.10

Very Poor
ROE (TTM)

-117.73

Very Poor
Net Margin (TTM)

-1084.17

Very Poor
Revenue

100.00 %

0
Net Profit

112.83 %

-142658.00 K
Debt to Equity

0.0189

Excellent
Altman Z Score

-1.89

Very Poor
Quick Ratio

0

Poor
Cash Ratio

8.28

Excellent


Highs/Lows of Adicet Bio Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week1.47 8.84 % 1.54 % 1.67991.3317-May-2414-May-24
Two Week1.45 10.34 % 3.42 % 1.8651.3307-May-2414-May-24
One Month2.27 29.52 % 5.60 % 2.291.3318-Apr-2414-May-24
Three Month2.94 45.58 % 5.95 % 3.041.3320-Feb-2414-May-24
Six Months1.2 33.33 % 17.48 % 3.76991.109-Jan-2429-Nov-23
One year6.67 76.01 % 27.52 % 6.711.118-May-2329-Nov-23
Two year12.32 87.01 % 29.70 % 21.871.111-Nov-2229-Nov-23
Five year55.16 97.10 % 85.46 % 21.871.111-Nov-2221-Nov-23


Technical View of Adicet Bio Inc
RSI

44.76

Neutral
MACD

-0.153

Mild Bullish
ADX

19.09

Neutral
Super Trend

1.94

Mild Bearish
Williams %R

-49.53

Neutral
CCI

-14.55

Neutral


EMA 5

1.52

Strong Bullish
EMA 15

1.59

Strong Bullish
EMA 50

1.90

Mild Bearish
EMA 100

2.08

Strong Bearish
SMA 100

2.30

Mild Bearish
SMA 200

1.92

Mild Bearish
SMA 5 / 20

1.47 / 1.62

Strong Bearish
SMA 15 / 50

1.53 / 1.97

Strong Bearish
SMA 50 / 200

1.97 / 1.92

Strong Bearish




Charts of Adicet Bio Inc


Returns of Adicet Bio Inc with Peers
Period / StockACETSMFRVIGLRGLS
1 Week8.84%-28.24%10.69%-9.50%
1 Mth-29.52%-15.05%20.55%-14.53%
3 Mth-45.58%25.22%16.17%30.72%
6mth33.33%-68.81%-12.00%38.89%
1 Year-76.01%-88.64%-58.56%22.70%
2 Year-87.01%-97.95%11.39%-0.695%
5 Years-97.10%---82.76%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Adicet Bio Inc with Peers
Ratio / StockACETSMFRVIGLRGLS
PE-123.39-0.160-412.18-763.41
P/B76.400.239250.51550.13
ROA-53.10-97.31-52.21-59.56
ROE-117.73-149.12-60.78-72.06
Debt To Equity0.01890.04880.00780.063
Revenue0
100.00 % 		234694 K
10.60 % 		0
% 		0
%
Net Income-142658.00 K
112.83 % 		-548980.00 K
123.72 % 		-78920.00 K
15.54 % 		-28771.00 K
1.58 %


Technicals of Adicet Bio Inc with Peers
Technical / StockACETSMFRVIGLRGLS-
ADX19.0915.6025.3121.58
CMF-0.527-0.0690.368-0.294
MFI61.8437.8582.0333.46
RSI44.7635.8257.3537.73
MACD Abv SignalTrueFalseTrueFalse
Price Above 50 MAFalseFalseTrueFalse-
Price Above 200 MAFalseFalseFalseTrue-


About : Adicet Bio Inc

Address : 131 Dartmouth Street, Boston, MA, United States, 02116
Tel : 650 503 9095
URL : https://www.adicetbio.com
Code : ACET, ISIN : US0070021086, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 26_Jan_2018
Employee Count : 143

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The company offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. Its lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. The company is also developing ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma for treating other CD70+ solid tumor and hematological malignancies indications. The company was founded in 2014 and is based in Boston, Massachusetts.


Note : All Data Generated at the End of Trading Hours (EOD Data)